Treatment of metastatic colorectal Cancer Aflibercept/FOLFIRI can be widely used in the second Therapy Line

被引：0
|
作者：
不详
机构：
来源：
ONCOLOGY RESEARCH AND TREATMENT | 2019年 / 42卷 / 06期
关键词：
FLUOROURACIL; LEUCOVORIN; IRINOTECAN; PLACEBO;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：358 / 358
页数：1
相关论文
共 50 条
  • [21] Predictors of the efficacy of FOLFIRI plus bevacizumab as second-line treatment in metastatic colorectal cancer patients
    Mitsukuni Suenaga
    Satoshi Matsusaka
    Masashi Ueno
    Noriko Yamamoto
    Eiji Shinozaki
    Nobuyuki Mizunuma
    Toshiharu Yamaguchi
    Kiyohiko Hatake
    Surgery Today, 2011, 41 : 1067 - 1074
  • [22] Aflibercept in the Treatment of Metastatic Colorectal Cancer
    Wang, Tzu-Fei
    Lockhart, Albert Craig
    CLINICAL MEDICINE INSIGHTS-ONCOLOGY, 2012, 6 : 19 - 30
  • [23] Efficacy and safety of folfiri plus aflibercept in second-line treatment of metastatic colorectal cancer: Real-life data from Turkish oncology group
    Erol, Cihan
    Sendur, Mehmet Ali Nahit
    Bilgetekin, Irem
    Garbioglu, Duygu Bayir
    Hamdard, Jamshid
    Akbas, Sinem
    Hizal, Mutlu
    Arslan, Cagatay
    Sevinc, Alper
    Kucukarda, Ahmet
    Erdem, Dilek
    Kahraman, Seda
    Cakir, Emre
    Demirkiran, Aykut
    On, Sercan
    Dogan, Izzet
    Erdogan, Atike Pinar
    Koca, Sinan
    Kubilay, Pinar
    Eren, Orhan Onder
    Cilbir, Ebru
    Celik, Emir
    Araz, Murat
    Ozyukseler, Deniz Tataroglu
    Yildirim, Mahmut Emre
    Bahceci, Aykut
    Taskaynatan, Halil
    Oyman, Abdilkerim
    Deniz, Gulhan Ipek
    Menekse, Serkan
    Kut, Engin
    Gulmez, Ahmet
    Sakin, Abdullah
    Nayir, Erdinc
    Acar, Ramazan
    Sen, Erdem
    Inal, Ali
    Turhal, Serdar
    Kaya, Ali Osman
    Paydas, Semra
    Tastekin, Didem
    Hacibekiroglu, Ilhan
    Cincin, Irfan
    Bilici, Ahmet
    Mandel, Nil Molinas
    Dede, Didem Sener
    Akinci, Muhammed Bulent
    Oksuzoglu, Berna
    Uncu, Dogan
    Yalcin, Bulent
    JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2022, 18 (09) : S347 - S353
  • [24] Erratum to: Aflibercept, a New Way to Target Angiogenesis in the Second Line Treatment of Metastatic Colorectal Cancer (mCRC)
    Mario Scartozzi
    Loic Vincent
    Marielle Chiron
    Stefano Cascinu
    Targeted Oncology, 2017, 12 : 123 - 123
  • [25] Second-line therapy for metastatic colorectal cancer
    Price, Timothy J.
    LANCET ONCOLOGY, 2015, 16 (05): : 476 - 477
  • [26] Safety and efficacy of FOLFIRI-bevacizumab for metastatic colorectal carcinoma as second line treatment
    Odabas, H.
    Ozdemir, N.
    Isik, M.
    Abali, H.
    Oksuzoglu, B.
    Kos, T.
    Civelek, B.
    Babacan, A. N.
    Dogan, U.
    Zengin, N.
    JOURNAL OF BUON, 2011, 16 (03): : 460 - 463
  • [27] Impact of omitting fluorouracil from FOLFIRI plus bevacizumab in second-line treatment of metastatic colorectal cancer
    Matsubara, Yuki
    Masuishi, Toshiki
    Ogata, Takatsugu
    Nakazawa, Taiko
    Kato, Kyoko
    Nozawa, Kazuki
    Narita, Yukiya
    Honda, Kazunori
    Bando, Hideaki
    Kadowaki, Shigenori
    Ando, Masashi
    Tajika, Masahiro
    Muro, Kei
    ANNALS OF ONCOLOGY, 2021, 32 : S321 - S321
  • [28] 4 cases of metastatic colorectal cancer treated by FOLFIRI plus Aflibercept (FOLFIRI plus AFL) after 3rd line
    Takemura, Shinichi
    Kamiga, Takahiro
    ANNALS OF ONCOLOGY, 2019, 30
  • [29] Maintenance with 5-FU/LV-aflibercept after induction with FOLFIRI-aflibercept versus FOLFIRI-aflibercept until progression as second-line treatment in older adults with metastatic colorectal cancer: the AFEMA phase II randomized trial
    Garcia-Alfonso, P.
    Elez, E.
    Soto-Alsar, J.
    Paez, D.
    Fernandez-Montes, A.
    Grana, B.
    Salud, A.
    Yubero, A.
    Gomez-Espana, M. A.
    Macias, I.
    Quintero, G.
    Lopez-Lopez, C.
    Fernandez-Rodriguez, T.
    Gravalos, C.
    Gonzalez-Flores, E.
    Guix, M.
    Paredes, B. Garcia
    Reina, J. J.
    Mowbray, J. R. Rodriguez
    Sastre, J.
    Aranda, E.
    ESMO OPEN, 2024, 9 (12)
  • [30] Impact of Anti-angiogenic Agents on Chemotherapy Efficacy in Patients With Metastatic Colorectal Cancer: Second-line FOLFIRI Plus Bevacizumab or Aflibercept
    Yamada, Yunami
    Matsuhashi, Nobuhisa
    Fujii, Hironori
    Makiyama, Akitaka
    Iihara, Hirotoshi
    Takahashi, Takao
    Watanabe, Daichi
    Kiyama, Shigeru
    Kobayashi, Ryo
    Suzuki, Akio
    Yoshida, Kazuhiro
    ANTICANCER RESEARCH, 2021, 41 (01) : 533 - 541
12345